Theaimwastoidentifyandquantifytheassociationbetweentheuseofparticularmedicationsduringthefirsttrimesterofpregnancy and selected congenital abnormalities (CAs) of newborns. Data were from the Czech National Registry of CAs. We used a case-control design , and collected total of 7285 cases and 9143 controls. Thiethylperazine and iron compounds had no effect on development of CAs.LoweroddsratioandpotentiallyprotectiveassociationswerefoundbetweenCAsandbioflavonoids,folicacid,progesterone, levothyroxine,andiodinetherapy.Sincetheprotectiveeffectofbioflavonoidswasnotdescribedbefore,analysisofinteractionwith otherdrugswasperformed.However,theirprotectiveeffectwasnotconfirmedandthestrongestsignificantprotectiveeffectwas detectedincombinationofbioflavonoidsandprogesterone.Increasedoddsratiowereidentifiedforhydroxyprogesterone,phenoxymethylpenicillin, aspirin, paracetamol and valproic acid. The association between paracetamol and congenital foot deformities was notsignificant,whilethesameassociationforthewholegroupofCAsanddeformitiesofmusculoskeletalsystemhadsignificantly increasedoddsratio.Exceptnewlydescribedeffectofbioflavonoids,ourresultsareinagreementwithriskcategoriesdefinedbyhealth authoritiesinUSAandAustralia,andwithresultsofotherstudies.Accordingtoourresults,paracetamoldoesnotinfluencedevelopment of congenital foot deformities.
Introduction
Congenital anomalies are a serious medical and social problem. About 10 % of congenital defects are caused by exogenous factors having effects on the developing embryo [1] , presenting a potential opportunity to prevent a range of congenital anomalies [2] . For 50-60% of congenital defects, on the other hand, the causal agent is not known. In these cases, they are caused by a combination of factors [1] . The teratogenic effect of various agents depends not only on their physical and chemical characteristics, but is also influenced by the dose, means of administration and gestational timing of exposure. The occurrences of other, concurrent exposures as well as the biological susceptibility of the mother and embryo or fetus also represent factors that may determine whether or not a particular exposure is likely to produce damage in a particular instance. The risk of major congenital anomalies in the general population is about 3-5%, but it may be much greater if the woman is at increased risk because of her age, positive family history, medical condition, or other exposures such as smoking, alcohol etc. [2] . As it is not ethically possible to test the teratogen risk on the developing fetus and as it is difficult to extrapolate findings in studies with laboratory animals, (although they help to explain A Population-based Case Control Study of Congenital Abnormalities and Medication Use During Pregnancy Using the Czech National Register of Congenital Abnormalities basic mechanisms of embryonic development and teratogen effect), epidemiological studies are the most important source of information. To assess risk of using specific drug during pregnancy, the Food and Drug Administration (FDA) in USA and the Australian Drug Evaluation Committee in Australia defined different risk categories of drugs according to their safety for prenatal development. Briggs et al. [3] summarized many papers concerning the risk of most frequently used drugs. There are also few other comprehensive reviews describing action of teratogenic agents [4] [5] [6] . To our knowledge, we are the first to have evaluated the effect of bioflavonoids (ATC group C05CA51) on development of the human embryo. In the Czech Republic, this group of drugs is often used to stop vaginal bleeding at the very beginning of pregnancy.
The aim of this study was to study influence of drug administration during the first trimester of pregnancy on the outcome of the newborn. We undertook a casecontrol study to identify and quantify associations between the use of particular drugs and selected congenital abnormalities (CAs) of newborns.
Material and Methods
The Czech Congenital Abnormality Registry is a national-wide registry. Physicians are required to record any observed CA as well as completing a questionnaire with the mother of the child concerning exposure to any drugs during the first trimester of pregnancy. The maximum number of CAs for each child is limited to four, and the maximum number of drugs is three. The dataset for this study, included entries in the Czech Congenital Abnormality Registry between years 1996 and 2003. We decided to consider each reported CA, rather than each child, as a case. If the mother of the child with CA was exposed to three different drugs, the CA was considered separately for each drug. CAs were diagnosed according to International Classification of Diseases. Our study population was 7285 cases of CAs. We selected to study CAs of urinary system and CAs and deformities of musculoskeletal system, because they are numerous and the critical period of these CAs is within the first trimester of pregnancy. For the larger group of CAs, which was CAs and deformities of musculoskeletal system, we could also determine associations for subgroups congenital foot deformities, polydactyly and syndactyly. Selected CAs are summarized in Table 1 . Drugs were sorted according to anatomicaltherapeutical-chemical (ATC) groups. Since Ascorutin® (rutosidum trihydricum 20 mg, acidum ascorbicum 100 mg) is the most prescribed drug in the group of bioflavonoids (total of 18 prescribed bioflavonoids in case group -12 Ascorutin®, 6 Anavenol® and total of 75 prescribed bioflavonoids in control group -72 Ascorutin®, 1 Anavenol®, 2 Venoruton®), we counted associations for Ascorutin® separately.
As controls, children without any defect born in the Institute for the Care of Mother and Child in Prague between 2001 and 2003 were considered. Information about exposure to any drugs during the first trimester of pregnancy was collected from the mothers during their stay in this hospital. We considered a maximum of three drugs per a child. Our study population consisted of 9 143 controls, 496 of which were exposed to any drug. The association between drug exposure and the occurrence of each CA was evaluated by odds ratio (OR). Using Woolf's technique, 95% confidence intervals (CI) were determined. The χ 2 test was counted to evaluate changes in frequency of prescribed drugs during the time (see Discussion). We determined associations only when the sum of cases and controls was higher than 10 and when each of them was higher than three to avoid any mistakes caused by small numbers.
Results
We evaluated associations between drug exposure and occurrence of CAs and we sorted results by CA (Table 2) and by drug ( Table 3) .
As the minimum number of controls and cases together was 10, the number of associations correlates with the number of cases in each group of CAs. The higher the number of cases, the higher the number of countable associations and consequently the higher the number of significant associations. The number of controls was the same for all groups of CAs.
The results of drug groups were influenced by the changing frequency of prescription during the years 1996-2003 (see Discussion). Despite this fact, bioflavonoids and Ascorutin® reached statistical significance in all 3 associations studied. Neither thietylperazine nor iron compounds had any relationship to the development of CAs. Protective associations were observed between CAs and folic acid (1 significant association of 3), progesterone (2 of 2), levothyroxine (3 of 3) and iodine therapy. Increased OR were found for hydroxyprogesterone (1 significant association of 1), phenoxymethylpenicillin (2 of 2), aspirin (1 of 1), paracetamol (3 of 5) and valproic acid (1 of 1).
We performed detailed analysis of bioflavonoids interaction with the other drugs to find out more about their potential protective effect. For this analysis we pooled both groups of CAs those of the urinary system and deformities of musculoskeletal system to avoid any mistake caused by small numbers. Out of 75 controls exposed to bioflavonoids, 21 were exposed to bioflavonoid only, 36 to bioflavonoid and progesterone and 18 to bioflavonoid and other drugs. Out of 15 cases exposed to bioflavonoids, 8 were exposed to bioflavonoid only, 2 to bioflavonoid and progesterone and 8 to bioflavonoid and various other drugs. We performed additional analysis of these selected groups and analysis of progesterone itself and progesterone and various other drugs (see Table 4 ).
Groups of bioflavonoids only and bioflavonoids and various other drugs were protective, but not statistically significant. The other examined associations were significant with protective effect. 
In the group of cases with CAs and deformities of musculoskeletal system, we could also determine associations for three subgroups of congenital foot deformities, polydactyly and syndactyly. Congenital foot deformities comprise 2589 of all 5095 cases of CAs and deformities of the musculoskeletal system. With the exception of paracetamol, associations studied in both CAs groups were comparable. While association between paracetamol and congenital foot deformities was not significant, the same association for CAs and deformities of musculoskeletal system, polydactyly and syndactyly had significantly increased OR.
Discussion
As the data in our study are retrospective, they could be influenced by recall and observer bias. This means that mothers of children with CAs are likely to be quizzed more intensely, and may reply more conscientiously than mothers of controls. This could result in an overestimation of drug risk by mothers whose children have CA. However, our most important results show possible protective association of bioflavonoids and CAs and no effect of paracetamol on congenital foot deformity; this type of bias would make our results even stronger. A more important problem of this study is the Table 5 .
Two ATC groups progesterone and valproic acid were more frequently prescribed during the years [2001] [2002] [2003] . Therefore, their OR should be higher then it was counted. In contrast, iron fumarate, hydroxyprogesterone, iodine therapy, phenoxymethylpenicillin and aspirin were more frequently prescribed between 1996 and 2000, and their OR should be lower then counted. Surprisingly, bioflavonoids belong to the second group and their strong protective association should be even stronger than observed. Remaining ATC groups, other combination of iron, folic acid, levothyroxine, paracetamol and thiethylperazine, did not change frequency in time.
CAs of urinary system
Well-known drugs which interfere in the development of the kidneys are inhibitors of angiotensin converting enzyme and antagonists of angiotensin II type 1 receptor [7, 8] . Undoubtedly, there are more biochemical modulators in this process than the renin-angiotensin system and angiotensin receptor. However, CAs of kidney and urinary tract very often take a familial pattern as Mendelian type of inheritance or as a complex trait resulting from a minor mutation of multiple specific genes that are involved in normal embryogenesis [9] . In our study, bioflavonoids, and especially Ascorutin®, were found to have significant protective associations. Progesterone was also significant but it was strongly influenced by changes in prescription frequency in time as described above. In contrast, no significance was observed in other combinations of iron, folic acid and notably paracetamol.
CAs and deformities of musculoskeletal system
Iron fumarate, other combinations of iron and thiethylperazine had no significant association. Iodine therapy was not found to be significant but because it was influenced by changes in prescription frequency in time, it would probably have slightly protective effect in reality. Levothyroxine has a quite strong significant protective association. Therapy either with folic acid or bioflavonoids and Ascorutin® led to significant protective associations. In our study, results of progesterone and hydroxyprogesterone were strongly influenced by changes in prescription frequency in time. In fact, the effect of these two drugs is probably neither as harmful as it appears (hydroxyprogesterone), or as protective, (progesterone). With the exception of paracetamol, all ATC groups with significant negative associations were influenced by changes in prescription frequency in time. In common population, OR of phenoxymethylpenicillin and aspirin would be lower. On the opposite, OR of valproic acid would be higher. Limb malformation belongs to the most visible and therefore most frequently reported phenotypic effect of teratogens. The specific effects of these teratogens include effect on limb morphogenesis (thalidomide, warfarin, phenytoin, valproic acid) and the effect of vascular disruption on a limb that had formed normally (misoprostol, chorionic villus sampling and phenytoin) [10] .
Congenital foot deformities
Congenital foot deformities make up more than the half of cases in CAs and deformities of musculoskeletal system (2589 of 5095 cases). Therefore, it is very interesting to compare results of these two groups of CAs. For both groups, associations of other combinations of iron and thiethylperazine were not found to be significant while bioflavonoids, Ascorutin® and levothyroxine, had significantly low OR. Phenoxymethylpenicillin had also significantly high OR in both CA groups. Surprisingly, paracetamol had no significant association with congenital foot deformities, while remaining significant in all CAs and deformities of musculoskeletal system. In conclusion, paracetamol and especially acute infectious disease or fever do not likely play as important role in developing congenital foot abnormalities as in developing other CAs of musculoskeletal system, namely reduction limb defects, polydactyly and syndactyly. The most frequent congenital foot deformity, club foot (1237 of 2589 congenital foot deformity cases in our study) could be influenced by heritability as incidence is different among races and sexes. Krogsgaard et al. [11] described that also exogenic factors are pathogenic. In their study, they found increasing incidence of club foot with higher population density. Except higher number of daily person-to-person contacts leading to higher exposure to infections, many other differences between high and low population density areas (e.g. diet, lifestyle, type of work) can theoretically represent exogenous factors influencing the risk of giving birth to child with club foot. Alderman et al. [12] support the pathogenic role of exogenic factors, when they demonstrated that the OR for club foot in boys was 2.6 in mothers who smoked, compared to non-smokers.
There were not many observed cases in both groups of CAs (999 cases of polydactyly and 828 cases of syndactyly). A significant relationship with paracetamol was present in both groups. In polydactyly, association of folic acid and levothyroxine could be determined, but they were not significant. Polydactyly and syndactyly occur very often together with other malformations or even different syndromes. Talamillo et al. [13] summarized mutations of different genes responsible for polydactyly. The work of Kazy et al. [14] describes higher incidence of polydactyly and syndactyly after maternal treatment with combination of vaginal metronidazole and miconazole during second through third month of gestation (OR=6, CI 2,4-15,2). To our knowledge, the effect of bioflavonoids (ATC group C05CA51) and namely of Ascorutin®, in embryogenesis has not been described before. As bioflavonoids were protective in most of CAs examined, their mode of action in embryogenesis has to be very general. In clinical practice, bioflavonoids are used to increase permeability and lower fragility of capillaries and these effects could be also very positive on veins of placenta. Furthermore, Ascorutin® contains 100 mg of vitamin C, which could increase maternal resistance to various infectious agents. More than one third of controls used bioflavonoids together with progesterone reflecting that such a drug combination is mostly indicated for vaginal bleeding in the beginning of pregnancy. Surprisingly, the combination of bioflavonoid and progesterone was the most protective association in our analysis. However, association analysis of drug interaction is influenced by bias caused by changes in the prescription frequency in time as well as by small number of exposed cases. Except for the newly described effect of bioflavonoids, our results were in agreement with risk categories defined by Food and Drug Administration in the USA [3] and by Australian Drug Evaluation Committee in Australia (www.tga.gov. au) and with other previously published studies [4] [5] [6] .
